IMMUNOMEDICS INC (24)

Browse by Contract Category

Contracts

Agreement and Plan of Merger, dated September 13, 2020, among Immunomedics, Inc., Gilead Sciences, Inc. and Maui Merger Sub, Inc (Filed With SEC on September 14, 2020)
Forms of Restricted Stock Units Notice and Restricted Stock Units Agreement (for Directors) under the Immunomedics, Inc. Amended and Restated 2014 Long-Term Incentive Plan (Filed With SEC on August 5, 2020)
Forms of Restricted Stock Units Notice and Restricted Stock Units Agreement (for Officers/Employees) under the Immunomedics, Inc. Amended and Restated 2014 Long-Term Plan (Filed With SEC on August 5, 2020)
Lease Agreement dated October 27, 2017 with WU/LH 400 American L.L.C (Filed With SEC on February 27, 2020)
Description of Securities of the Registrant, dated as of December 31, 2019 (Filed With SEC on February 27, 2020)
License Agreement, dated as of April 29, 2019, by and between Immunomedics, Inc. and Everest Medicines II Limited (Filed With SEC on August 7, 2019)
Sales Agreement, dated as of March 29, 2019, by and between Immunomedics, Inc. and Cowen and Company, LLC (Filed With SEC on March 29, 2019)
Forms of Nonqualified Stock Option Notice and Nonqualified Stock Option Agreement under the Immunomedics, Inc. Amended and Restated 2014 Long-Term Incentive Plan (Filed With SEC on August 5, 2020)
Forms of Incentive Stock Option Notice and Incentive Stock Option Agreement under the Immunomedics, Inc. Amended and Restated 2014 Long-Term Incentive Plan (Filed With SEC on August 5, 2020)
Immunomedics, Inc. Amended and Restated 2014 Long-Term Incentive Plan (Filed With SEC on June 18, 2020)
Separation Agreement, dated May 27, 2020, by and between Immunomedics, Inc. and Harout Semerjian (Filed With SEC on May 27, 2020)
Executive Employment Agreement, dated as of April 16, 2020, by and between the Company and Harout Semerjian (Filed With SEC on May 6, 2020)
Performance-Based Restricted Stock Unit Agreement, dated as of April 16, 2020, by and between the Company and Harout Semerjian (Filed With SEC on May 6, 2020)
Time-Based Restricted Stock Unit Agreement, dated as of April 16, 2020, by and between the Company and Harout Semerjian (Filed With SEC on May 6, 2020)
Nonqualified Stock Option Grant, dated as of April 16, 2020, by and between the Company and Harout Semerjian (Filed With SEC on May 6, 2020)
Incentive Stock Option Grant, dated as of February 13, 2020, by and between the Company and Loretta Itri (Filed With SEC on May 6, 2020)
Executive Employment Agreement, dated as of February 13, 2020, by and between the Company and Loretta Itri (Filed With SEC on May 6, 2020)
Underwriting Agreement by and among Immunomedics, Inc., Cowen and Company, LLC, BofA Securities, Inc. and Jefferies LLC, as representatives of the underwriters named therein,... (Filed With SEC on May 1, 2020)
Underwriting Agreement by and among the Company, Goldman Sachs & Co. LLC and BofA Securities, Inc., as representatives of the underwriters named therein, dated December 4, 2019 (Filed With SEC on December 9, 2019)
Promotion Agreement, dated as of April 5, 2019, by and between Immunomedics, Inc. and Janssen Biotech, Inc (Filed With SEC on August 7, 2019)
Consulting Agreement, dated as of May 28, 2019, by and between Immunomedics, Inc. and Dr. Robert Iannone (Filed With SEC on August 7, 2019)
Letter Agreement, dated as of March 5, 2019, by and between the Company and Scott Canute (Filed With SEC on May 9, 2019)
Executive Employment Agreement, dated as of August 7, 2017, by and between the Company and Usama Malik (Filed With SEC on May 9, 2019)
Separation Agreement, dated as of March 13, 2019, by and between the Company and Michael Pehl (Filed With SEC on May 9, 2019)